A Comparison of effect of Kantakaryadi Kwatha and Bhunimbadi Kwatha in Acidity

A Comparative Phase 2 clinical study to evaluate efficacy of Kantakaryadi Kwatha and Bhunimbadi Kwatha in Urdhavag Amlapitta

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/09/028034

Enrollment

Registered

2020-09-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: Kantakaryadi Kwatha: 40 ml twice a daily before meal for 21 days Control Intervention1: Bhunimbadi Kwatha: 40 ml twice a daily before meal for 21 days

Eligibility

Inclusion criteria

Inclusion criteria: Obesity induce hyperacidity Patients fulfilling the diagnostic criteria which are based on sign and symptoms of amlapitta

Exclusion criteria

Exclusion criteria: Patient not willing for clinical trial Pregnant and lactating mothers Patients suffering from any other chronic systemic disorders stomach abnormality like hiatus hernia Connective tissue disorders such as scleroderma Taking other medicine like aspirin ibuprofen Non steroidal anti inflammatory drugs High blood pressure medicine Iron supplements tricyclic antidepressants Anti-anxiety drugs etc

Design outcomes

Primary

Measure	Time frame
Reduction of acid refluxTimepoint: 21 days	—

Secondary

Measure	Time frame
Reduction of associate symptoms related to acidityTimepoint: 21 days	—

Countries

India

Contacts

Public ContactDr Rajan B Kulkarni

Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik Maharashtra

vaidyarajankulkarni@gmail.com9823350440

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026